Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Acetaminophen selectively suppresses peripheral prostaglandin E2 release and increases COX-2 gene expression in a clinical model of acute inflammation.

Lee YS, Kim H, Brahim JS, Rowan J, Lee G, Dionne RA.

Pain. 2007 Jun;129(3):279-86. Epub 2006 Dec 18.

PMID:
17175104
2.

The differential effects of bupivacaine and lidocaine on prostaglandin E2 release, cyclooxygenase gene expression and pain in a clinical pain model.

Gordon SM, Chuang BP, Wang XM, Hamza MA, Rowan JS, Brahim JS, Dionne RA.

Anesth Analg. 2008 Jan;106(1):321-7, table of contents. doi: 10.1213/01.ane.0000296474.79437.23.

PMID:
18165598
3.

Analgesia and COX-2 inhibition.

Dionne RA, Khan AA, Gordon SM.

Clin Exp Rheumatol. 2001 Nov-Dec;19(6 Suppl 25):S63-70. Review.

PMID:
11695255
4.

Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue injury model.

Gordon SM, Brahim JS, Rowan J, Kent A, Dionne RA.

Clin Pharmacol Ther. 2002 Aug;72(2):175-83.

PMID:
12189364
5.

In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model.

Khan AA, Brahim JS, Rowan JS, Dionne RA.

Clin Pharmacol Ther. 2002 Jul;72(1):44-9.

PMID:
12152003
6.

Dexamethasone suppresses peripheral prostanoid levels without analgesia in a clinical model of acute inflammation.

Dionne RA, Gordon SM, Rowan J, Kent A, Brahim JS.

J Oral Maxillofac Surg. 2003 Sep;61(9):997-1003.

PMID:
12966473
9.
12.

Comparative study of intravenous Tramadol versus Ketorolac for preventing postoperative pain after third molar surgery--a prospective randomized study.

Gopalraju P, Lalitha RM, Prasad K, Ranganath K.

J Craniomaxillofac Surg. 2014 Jul;42(5):629-33. doi: 10.1016/j.jcms.2013.09.004. Epub 2013 Sep 25.

PMID:
24269645
13.

Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.

Jaworek J, Bonior J, Tomaszewska R, Jachimczak B, Kot M, Bielański W, Pawlik WW, Sendur R, Stachura J, Konturek PC, Konturek SJ.

J Physiol Pharmacol. 2001 Mar;52(1):107-26.

14.

Cyclooxygenase-2 induction after oral surgery does not entirely account for analgesia after selective blockade of cyclooxygenase 2 in the preoperative period.

Fornai M, Colucci R, Graziani F, Cei S, Antonioli L, Tonelli M, Vassalle C, Blandizzi C, Gabriele M, Del Tacca M.

Anesthesiology. 2006 Jan;104(1):152-7.

PMID:
16394701
15.
16.

Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain.

Wang XM, Wu TX, Hamza M, Ramsay ES, Wahl SM, Dionne RA.

Pain. 2007 Mar;128(1-2):136-47. Epub 2006 Oct 27.

17.

Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model.

Ehrich EW, Dallob A, De Lepeleire I, Van Hecken A, Riendeau D, Yuan W, Porras A, Wittreich J, Seibold JR, De Schepper P, Mehlisch DR, Gertz BJ.

Clin Pharmacol Ther. 1999 Mar;65(3):336-47.

PMID:
10096266
18.

Ketorolac and diclofenac for postoperative pain relief following oral surgery.

Walton GM, Rood JP, Snowdon AT, Rickwood D.

Br J Oral Maxillofac Surg. 1993 Jun;31(3):158-60.

PMID:
8512909
19.

Ketorolac versus acetaminophen-codeine in the emergency department treatment of acute low back pain.

Innes GD, Croskerry P, Worthington J, Beveridge R, Jones D.

J Emerg Med. 1998 Jul-Aug;16(4):549-56.

PMID:
9696169
20.

Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trial.

Morrison BW, Christensen S, Yuan W, Brown J, Amlani S, Seidenberg B.

Clin Ther. 1999 Jun;21(6):943-53.

PMID:
10440619

Supplemental Content

Support Center